Validation of nasospheroids to assay CFTR functionality and modulator responses in cystic fibrosis

Abstract The availability of a simple, robust and non-invasive in vitro airway model would be useful to study the functionality of the cystic fibrosis transmembrane regulator (CFTR) protein and to personalize modulator therapy for cystic fibrosis (CF) patients. Our aim was to validate a CFTR functio...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maite Calucho, Silvia Gartner, Paula Barranco, Paula Fernández-Álvarez, Raquel García Pérez, Eduardo F. Tizzano
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ceebc254ff6749ddae89f16c9505710e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ceebc254ff6749ddae89f16c9505710e
record_format dspace
spelling oai:doaj.org-article:ceebc254ff6749ddae89f16c9505710e2021-12-02T18:47:07ZValidation of nasospheroids to assay CFTR functionality and modulator responses in cystic fibrosis10.1038/s41598-021-94798-x2045-2322https://doaj.org/article/ceebc254ff6749ddae89f16c9505710e2021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-94798-xhttps://doaj.org/toc/2045-2322Abstract The availability of a simple, robust and non-invasive in vitro airway model would be useful to study the functionality of the cystic fibrosis transmembrane regulator (CFTR) protein and to personalize modulator therapy for cystic fibrosis (CF) patients. Our aim was to validate a CFTR functional study using nasospheroids, a patient-derived nasal cell 3D-culture. We performed live-cell experiments in nasospheroids obtained from wild-type individuals and CF patients with different genotypes and phenotypes. We extended the existing method and expanded the analysis to upgrade measurements of CFTR activity using forskolin-induced shrinking. We also tested modulator drugs in CF samples. Immobilizing suspended-nasospheroids provided a high number of samples for live-cell imaging. The diversity observed in basal sizes of nasospheroids did not affect the functional analysis of CFTR. Statistical analysis with our method was simple, making this protocol easy to reproduce. Moreover, we implemented the measurement of inner fluid reservoir areas to further differentiate CFTR functionality. In summary, this rapid methodology is helpful to analyse response to modulators in CF samples to allow individualized treatment for CF patients.Maite CaluchoSilvia GartnerPaula BarrancoPaula Fernández-ÁlvarezRaquel García PérezEduardo F. TizzanoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Maite Calucho
Silvia Gartner
Paula Barranco
Paula Fernández-Álvarez
Raquel García Pérez
Eduardo F. Tizzano
Validation of nasospheroids to assay CFTR functionality and modulator responses in cystic fibrosis
description Abstract The availability of a simple, robust and non-invasive in vitro airway model would be useful to study the functionality of the cystic fibrosis transmembrane regulator (CFTR) protein and to personalize modulator therapy for cystic fibrosis (CF) patients. Our aim was to validate a CFTR functional study using nasospheroids, a patient-derived nasal cell 3D-culture. We performed live-cell experiments in nasospheroids obtained from wild-type individuals and CF patients with different genotypes and phenotypes. We extended the existing method and expanded the analysis to upgrade measurements of CFTR activity using forskolin-induced shrinking. We also tested modulator drugs in CF samples. Immobilizing suspended-nasospheroids provided a high number of samples for live-cell imaging. The diversity observed in basal sizes of nasospheroids did not affect the functional analysis of CFTR. Statistical analysis with our method was simple, making this protocol easy to reproduce. Moreover, we implemented the measurement of inner fluid reservoir areas to further differentiate CFTR functionality. In summary, this rapid methodology is helpful to analyse response to modulators in CF samples to allow individualized treatment for CF patients.
format article
author Maite Calucho
Silvia Gartner
Paula Barranco
Paula Fernández-Álvarez
Raquel García Pérez
Eduardo F. Tizzano
author_facet Maite Calucho
Silvia Gartner
Paula Barranco
Paula Fernández-Álvarez
Raquel García Pérez
Eduardo F. Tizzano
author_sort Maite Calucho
title Validation of nasospheroids to assay CFTR functionality and modulator responses in cystic fibrosis
title_short Validation of nasospheroids to assay CFTR functionality and modulator responses in cystic fibrosis
title_full Validation of nasospheroids to assay CFTR functionality and modulator responses in cystic fibrosis
title_fullStr Validation of nasospheroids to assay CFTR functionality and modulator responses in cystic fibrosis
title_full_unstemmed Validation of nasospheroids to assay CFTR functionality and modulator responses in cystic fibrosis
title_sort validation of nasospheroids to assay cftr functionality and modulator responses in cystic fibrosis
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/ceebc254ff6749ddae89f16c9505710e
work_keys_str_mv AT maitecalucho validationofnasospheroidstoassaycftrfunctionalityandmodulatorresponsesincysticfibrosis
AT silviagartner validationofnasospheroidstoassaycftrfunctionalityandmodulatorresponsesincysticfibrosis
AT paulabarranco validationofnasospheroidstoassaycftrfunctionalityandmodulatorresponsesincysticfibrosis
AT paulafernandezalvarez validationofnasospheroidstoassaycftrfunctionalityandmodulatorresponsesincysticfibrosis
AT raquelgarciaperez validationofnasospheroidstoassaycftrfunctionalityandmodulatorresponsesincysticfibrosis
AT eduardoftizzano validationofnasospheroidstoassaycftrfunctionalityandmodulatorresponsesincysticfibrosis
_version_ 1718377707488673792